BC Centre for Excellence in HIV/AIDS

B.C. leads global HIV prevention to save lives

The BC Centre for Excellence in HIV/AIDS (BC-CfE) is Canada’s largest HIV/AIDS research, treatment, and education facility. 

Dr. Julio Montaner is physician-in-chief at the BC Centre for Excellence in HIV/AIDS. Photo by Arlen Redekop/PNG


Led many highly successful earned media campaigns for the BC Centre for Excellence in HIV/AIDS, often involving prominent and sensitive issues such as proactive testing and treatment of at‑risk populations, supervised consumption sites, science-based drug policies, and milestone announcements involving the provincial government.

The work routinely required translating complex scientific research into clear, consistent, and compelling messages and narratives for different audiences. It also required understanding the complexities of the BC-CfE’s work landscape. As a key provincial resource, the organization serves all health authorities, regions, and people living in B.C. while working closely with healthcare professionals, government partners, academics, and patients.

We provided the full suite of media relations services, including writing and distributing news releases and media advisories; media training and one-on-one preparation for spokespeople before media interviews; pitching and securing timely op-eds in appropriate media outlets; pitching and securing regular media coverage; and coordinating interviews. 

Over the years, the BC-CfE and its research were covered extensively by Canadian and international media, including The Globe and Mail, National Post, Toronto Star, CBC, Global TV, The New York Times, BBC, Associated Press, The Wall Street Journal, CNN, The Economist, The Guardian, and Reuters. 


Impact

This regular and high-profile media coverage established Dr. Julio Montaner as a go-to global leader on ground-breaking HIV and AIDS research and treatment in B.C., Canada, and internationally. It also played a key role in the worldwide adoption of the BC-CfE-pioneered highly active antiretroviral therapy (the gold standard treatment) and the Treatment as Prevention strategy, significantly reducing the incidence of HIV and AIDS‑related diseases and deaths.


In the News

Next
Next

Verisante Technology, Inc.